68236-35-1

Usage

Uses

Used in Pharmaceutical Industry:
2-BROMO-6-CHLOROTHIENO[2,3-B]PYRIDINE is used as a key intermediate in the synthesis of various pharmaceutical compounds due to its unique structure and reactivity. It contributes to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
2-BROMO-6-CHLOROTHIENO[2,3-B]PYRIDINE is used as a building block in the synthesis of agrochemicals, particularly as a potential pesticide. Its unique chemical properties allow for the development of effective pest control agents.
Used in Antifungal Applications:
2-BROMO-6-CHLOROTHIENO[2,3-B]PYRIDINE has been studied for its potential use as an antifungal agent. Its chemical structure and reactivity may contribute to the development of new antifungal compounds to combat fungal infections.
Used in Research and Development:
2-BROMO-6-CHLOROTHIENO[2,3-B]PYRIDINE is utilized in the research and development of new chemical compounds due to its unique structure and reactivity. It serves as a valuable tool for exploring novel chemical reactions and synthesizing innovative compounds with potential applications in various industries.

InChI:InChI=1/C7H3BrClNS/c8-5-3-4-1-2-6(9)10-7(4)11-5/h1-3H

Upstream product

• 68236-26-0 N-(5-bromothiophen-2-yl)acetamide 
• 68-12-2 N,N-dimethyl-formamide 
• 5370-25-2 2-Acetyl-5-bromothiophene 

Downstream Products

• 68236-39-5 6-bromo-2-phenylthiothieno<2,3-b>pyridine 
• 272-23-1 thieno[2,3-b]pyridine 
• 62226-18-0 6-chlorothieno[2,3-b]pyridine 
• 1286768-38-4 2-methyl-2-(4-((6-(6-methylthieno[2,3-b]pyridin-2-yl)-3-nitroquinolin-4-yl)methyl)phenyl)propanenitrile 

Relevant academic research and scientific papers

AMINOISOXAZOLINE COMPOUNDS AS AGONISTS OF ALPHA7-NICOTINIC ACETYLCHOLINE RECEPTORS

The present invention relates to novel aminoisoxazoline compounds, and pharmaceutical compositions of the same, that are suitable as agonists or partial agonists of α7-nAChR, and methods of preparing these compounds and compositions, and the use of these compounds and compositions in methods of maintaining, treating and/or improving cognitive function. In particular, methods of administering the compound or composition to a patient in need thereof, for example a patient with a cognitive deficiency and/or a desire to enhance cognitive function, that may derive a benefit therefrom.

Synthesis of the fused heterobicycles 5-pyridin-2-yl-thieno[3,2-b]pyridine, 6-pyridin-2-yl-thieno[2,3-b]pyridine and 6-pyridin-2-yl-thieno[3,2-c]pyridine

Three new pyridyl thienopyridines, 5-pyridin-2-yl-thieno[3,2-b]pyridine, 6-pyridin-2-yl-thieno[2,3-b]pyridine and 6-pyridin-2-yl-thieno[3,2-c]pyridine, have been synthesized, each through a different synthetic sequence. Overall yields ranged from 8% to 32%. Georg Thieme Verlag Stuttgart.

Sulfonic acid sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds

The compounds of formula I herein exhibit useful pharmacological activity and accordingly are incorporated into pharmaceutical compositions and used in the treatment of patients suffering from certain medical disorders. More specifically, they are inhibitors of the activity of Factor Xa. The present invention is directed to compounds of formula I, compositions containing compounds of formula I, and their use, for treating a patient suffering from, or subject to, a physiological condition which can be ameliorated by the administration of an inhibitor of the activity of Factor Xa.

Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds

The compounds of formula I exhibit useful pharmacological activity and accordingly are incorporated into pharmaceutical compositions and used in the treatment of patients suffering from certain medical disorders. More specifically, they are inhibitors of the activity of Factor Xa. The present invention is directed to compounds of formula I, compositions containing compounds of formula I, and their use, which are for treating a patient suffering from, or subject to, physiological condition which can be ameliorated by the administration of an inhibitor of the activity of Factor Xa.

SUBSTITUTED SULFONIC ACID N-[(AMINOIMINOMETHYL)PHENYLALKYL]-AZAHETEROCYCLAMIDE COMPOUNDS

The compounds of formula I exhibit useful pharmacological activity and accordingly are incorporated into pharmaceutical compositions and used in the treatment of patients suffering from certain medical disorders. More specifically, they are inhibitors of the activity of Factor Xa. The present invention is directed to compounds of formula I, compositions containing compounds of formula I, and their use, which are for treating a patient suffering from, or subject to, physiological condition which can be ameliorated by the administration of an inhibitor of the activity of Factor Xa.

A Versatile New Synthesis of Quinolines and Related Fused Pyridines. Part 7. The Conversion of Acetamidothiophens into Thienopyridines

5-Substituted-2-acetamidothiophens are converted into 2-acetamidothiophen-3-carbaldehydes in good yield with equimolar amounts of dimethylformamide and phosphoryl chloride in hot dichloroethane.However, under similar conditions but with three mol of phosp